Redox tuning of Ca²⁺ signaling in microglia drives glutamate release during hypoxia

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Hypoxia during brain ischemia induces oxidative stress and excitotoxicity, leading to neuronal damage.
• Activated microglia release glutamate, exacerbating excitotoxicity in brain insults.
• Understanding microglial glutamate release mechanisms is crucial for therapeutic development.

Purpose of the Study:

• To elucidate the signaling pathway controlling glutamate release from human microglia under hypoxic conditions.
• To investigate the role of calcium signaling and Src kinase in hypoxia-induced microglial activation.
• To evaluate the potential of antioxidants in mitigating hypoxia-mediated glutamate release.

Main Methods:

• Investigated hypoxia-induced changes in human microglia.
• Analyzed endoplasmic reticulum inositol 1,4,5-trisphosphate (InsP3) receptor activation and calcium (Ca2+) mobilization.
• Assessed the involvement of protein tyrosine kinase Src and microglial gap junctions.
• Utilized dietary antioxidants (neochlorogenic acid, vitamin C) to block signaling pathways.

Main Results:

• Hypoxia-induced redox imbalance activates InsP3 receptors, leading to increased cytosolic Ca2+ in microglia.
• Elevated Ca2+ activates Src kinase, enhancing gap junction permeability and glutamate release.
• Antioxidants targeting redox imbalance successfully inhibited Ca2+ signaling and glutamate release.

Conclusions:

• A novel pathway involving redox imbalance, InsP3 receptors, Ca2+ signaling, and Src kinase mediates glutamate release from microglia during hypoxia.
• Modulating microglial calcium signaling represents a potential therapeutic target to control glutamate excitotoxicity in brain ischemia.
• Dietary antioxidants show promise in preventing hypoxia-driven neuronal damage by inhibiting microglial glutamate release.